Skip to main content
Log in

Reliability and validity of the Chinese version of the questionnaire of olfactory disorders (QOD) when used with patients having olfactory dysfunction

  • Head and Neck
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

To cross-culturally adapt the Questionnaire of olfactory disorders (QOD) into a Chinese version, and then evaluate its reliability and validity for testing patients with olfactory dysfunction. A Chinese version of the QOD was evaluated for test–retest reliability, split-half reliability, and internal consistency. The validity analysis included components of content validity and criterion-related validity, as well as comparisons between The Medical Outcomes Study’s36-Item ShortForm Health Survey(SF-36)questionnaire and the WHO Quality of Life-BREF (WHOQOL-BREF)questionnaire. A total of 125 patients with olfactory dysfunction were tested, and 104 patients completed three different surveys (QOD, SF-36, and WHOQOL-BREF). The test–retest reliabilities of the QOD-Parosmia statements (QOD-P), QOD-Quality of life (QOD-QoL), and QOD-Visual simulation (QOD-VAS)sections were 0.802 (P < 0.001), 0.797 (P < 0.001), and 0.468 (P < 0.001), respectively, and the Cronbach’s α coefficients of internal consistency were 0.473, 0.814, and 0.882, respectively. The split-half reliability was 0.70. No correlation was found between the QOD-P section and the SF-36; however, there were statistically significant correlations between the QOD-QoL andQOD-VAS sections and the SF-36. The same results were observed for correlations between the QOD and WHOQOL-BREF. The Chinese version of the QOD was proven to be a generally reliable and valid questionnaire for use in evaluating mainland Chinese patients suspected of having olfactory dysfunction. However, the QOD-P section requires further modifications to properly evaluate patients with a Chinese cultural background and type of cognition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Nordin S, Bramerson A, Millqvist E, Bende M (2007) Prevalence of parosmia: the Skovde population-based studies. Rhinology 45(1):50–53

    PubMed  Google Scholar 

  2. Neuland C, Bitter T, Marschner H, Gudziol H, Guntinas-Lichius O (2011) Health-related and specific olfaction-related quality of life in patients with chronic functional anosmia or severe hyposmia. Laryngoscope 121(4):867–872. doi:10.1002/lary.21387

    Article  PubMed  Google Scholar 

  3. Simopoulos E, Katotomichelakis M, Gouveris H, Tripsianis G, Livaditis M, Danielides V (2012) Olfaction-associated quality of life in chronic rhinosinusitis: adaptation and validation of an olfaction-specific questionnaire. Laryngoscope 122(7):1450–1454. doi:10.1002/lary.23349

    Article  PubMed  Google Scholar 

  4. Katotomichelakis M, Simopoulos E, Zhang N, Tripsianis G, Danielides G, Livaditis M, Bachert C, Danielides V (2013) Olfactory dysfunction and asthma as risk factors for poor quality of life in upper airway diseases. Am J Rhinol Allergy 27(4):293–298. doi:10.2500/ajra.2013.27.3903

    Article  PubMed  Google Scholar 

  5. Guan J, Ni DF, Wang J, Liu JF, Zhu YY (2012) Application of unilateral olfactory testing and clinical analysis of unilateral hyposmia. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 47(11):945–947

    PubMed  Google Scholar 

  6. Yang L, Wei Y, Zhang W, Ren Y, Yu D, Li K, Guo Y, Zhang J (2012) Clinical examination of olfactory and gustatory function. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 26(14):625–628

    PubMed  Google Scholar 

  7. Xiao Q, Chen S, Le W (2014) Hyposmia: a possible biomarker of Parkinson’s disease. Neurosci Bull 30(1):134–140. doi:10.1007/s12264-013-1390-3

    Article  CAS  PubMed  Google Scholar 

  8. Wu X, Yu C, Fan F, Zhang K, Zhu C, Wu T, Li K, Chan P (2011) Correlation between progressive changes in piriform cortex and olfactory performance in early Parkinson’s disease. Eur Neurol 66(2):98–105. doi:10.1159/000329371

    Article  PubMed  Google Scholar 

  9. Hu J, Wang X, Liu D, Wang Q, Zhu LQ (2012) Olfactory deficits induce neurofilament hyperphosphorylation. Neurosci Lett 506(2):180–183. doi:10.1016/j.neulet.2011.10.076

    Article  CAS  PubMed  Google Scholar 

  10. Guo S, Li L, Dai Y et al (2015) Correlations between olfactory and cognitive functions in early stage Parkinson’s disease. Zhonghua Yi Xue Za Zhi 95(7):489–492

    PubMed  Google Scholar 

  11. Li L, Wang H, Shen Y (2002) Development and psychometric tests of a Chinese version of the SF-36 health survey scales. Zhonghua Yu Fang Yi Xue Za Zhi 36(2):109–113

    PubMed  Google Scholar 

  12. F J, H Y, L C (1999) Reliability and validity for Chinese version of WHO quality of life scale. Chin Mental Health J 13 (4):203–205

  13. Frasnelli J, Hummel T (2005) Olfactory dysfunction and daily life. Eur Arch Otorhinolaryngol 262(3):231–235. doi:10.1007/s00405-004-0796-y

    Article  PubMed  Google Scholar 

  14. Smeets MA, Veldhuizen MG, Galle S, Gouweloos J, de Haan AM, Vernooij J, Visscher F, Kroeze JH (2009) Sense of smell disorder and health-related quality of life. Rehabil Psychol 54(4):404–412. doi:10.1037/a0017502

    Article  PubMed  Google Scholar 

  15. Turner-Bowker DM, Saris-Baglama RN, DeRosa MA, Giovannetti ER, Jensen RE, Wu AW (2012) A computerized adaptive version of the SF-36 is feasible for clinic and Internet administration in adults with HIV. AIDS Care 24(7):886–896. doi:10.1080/09540121.2012.656573

    Article  PubMed  Google Scholar 

  16. Yang Z, Li W, Tu X, Tang W, Messing S, Duan L, Pan J, Li X, Wan C (2012) Validation and psychometric properties of Chinese version of SF-36 in patients with hypertension, coronary heart diseases, chronic gastritis and peptic ulcer. Int J Clin Pract 66(10):991–998. doi:10.1111/j.1742-1241.2012.02962.x

    Article  CAS  PubMed  Google Scholar 

  17. Klosinski M, Tomaszewski KA, Tomaszewska IM, Klosinski P, Skrzat J, Walocha JA (2014) Validation of the Polish language version of the SF-36 health survey in patients suffering from lumbar spinal stenosis. Ann Agric Environ Med 21(4):866–870. doi:10.5604/12321966.1129948

    Article  PubMed  Google Scholar 

  18. Zampelis V, Ornstein E, Franzen H, Atroshi I (2014) A simple visual analog scale for pain is as responsive as the WOMAC, the SF-36, and the EQ-5D in measuring outcomes of revision hip arthroplasty. Acta Orthop 85(2):128–132. doi:10.3109/17453674.2014.887951

    Article  PubMed  PubMed Central  Google Scholar 

  19. van Es J, den Exter PL, Kaptein AA, Andela CD, Erkens PM, Klok FA, Douma RA, Mos IC, Cohn DM, Kamphuisen PW, Huisman MV, Middeldorp S (2013) Quality of life after pulmonary embolism as assessed with SF-36 and PEmb-QoL. Thromb Res 132(5):500–505. doi:10.1016/j.thromres.2013.06.016

    Article  PubMed  Google Scholar 

  20. Hummel T, Lotsch J (2010) Predictors of prognosis in patients with olfactory dysfunction include initial olfactory diagnosis and the etiology of olfactory loss. Arch Otolaryngol Head Neck Surg 136:347–351

    Article  PubMed  Google Scholar 

  21. Landis BN, Frasnelli J, Croy I, Hummel T (2010) Evaluating the clinical usefulness of structured questions in parosmia assessment. Laryngoscope 120(8):1707–1713. doi:10.1002/lary.20955

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This article was supported by a grant from the National Natural Science Foundation (No: H1301 81300816).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jian Wang.

Ethics declarations

Conflict of interest

The authors declare having no conflicts of interest associated with this study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yang, D., Wang, J., Ni, D. et al. Reliability and validity of the Chinese version of the questionnaire of olfactory disorders (QOD) when used with patients having olfactory dysfunction. Eur Arch Otorhinolaryngol 273, 3255–3261 (2016). https://doi.org/10.1007/s00405-015-3869-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-015-3869-1

Keywords

Navigation